#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Iron overload Hodgkin's disease refractory Vitamin B12 deficiency Oesophageal squamous cell carcinoma stage II Systemic mastocytosis Pulmonary tuberculosis Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Chronic graft versus host disease Eosinophilic oesophagitis Antithrombin III deficiency Cutaneous T-cell lymphoma recurrent Hereditary motor and sensory neuropathy Congenital nephrogenic diabetes insipidus Metabolic disorder Hereditary hypophosphataemic rickets More trials…

    Learn about Rare Diseases

    Synovial sarcoma recurrent – Diagnostics Anaplastic thyroid cancer – Life with Disease Glycogen storage disease type V – Treatment Alagille syndrome Chronic granulomatous disease – Trials in Disease Basal cell naevus syndrome Retinoblastoma – Diagnostics Hairy cell leukaemia – Life with Disease Haemophilia – Basic Information Soft tissue sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Nitrite Gns561 Anidulafungin SARACATINIB VG801-2 Valbenazine Ditosylate Gadoquatrane Dexmedetomidine Ademetionine Vixarelimab Dorocubicel Cloxacillin Soticlestat Mifamurtide Foscarnet Trehalose Dihydrate (Ph.eur.) Radium Ra 223 Dichloride N-Acetylhistidine Ace Inhibitors, Plain Immunoglobulin M More therapies…

    Learn about Your Condition

    Pulmonary hypertension Lumbosacral radiculopathy Juvenile spondyloarthritis Plasma cell myeloma Ichthyosis Appendicitis Laparotomy Subdural haematoma Breast cancer recurrent BRAF gene mutation Fragile X syndrome Fibrosarcoma metastatic Head and neck cancer Metastases to liver Richter's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Varsinais-Suomen hyvinvointialue

Varsinais-Suomen hyvinvointialue

Kiinamyllynkatu 4-8, Turku, 20520, Finland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Estradiol and Exercise to Reduce Side Effects of Androgen Deprivation Therapy in Prostate Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Estradiol
    • Leuprorelin Acetate
    • Relugolix
    Finland

  • Study on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • 2,4,6,7,8,9-Hexahydro-4-((2-Methylphenyl)Methyl)-7-(Phenylmethyl)Imidazo(1,2-A)Pyrido(3,4-E)Pyrimidin-5(1H)-One
    • Everolimus
    Austria Belgium Czechia Denmark Finland France +5

  • Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Hydrocortisone Sodium Phosphate
    • Hydrocortisone Sodium Succinate
    • Inotuzumab Ozogamicin
    Belgium Denmark Estonia Finland France Germany +8

  • Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lomustine
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Denmark Finland Germany +4

  • Effect of methohexital, propofol, and etomidate on electroconvulsive therapy outcomes in patients with severe depression

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Propofol
    Finland

  • Safety and tolerability study of S-241656 with posaconazole in patients with AML, MDS/AML or CMML

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • S-241656
    • Posaconazole
    Finland France Germany Italy The Netherlands Spain

  • Diagnostic Accuracy of [18F]FAPI-74 PET/CT for Detecting Metastasis and Assessing Treatment Response in Gastric Cancer Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Finland

  • A study testing hydroxychloroquine to reduce brain inflammation in patients with progressive multiple sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    Finland

  • Study on Fecal Microbiota Transplantation with Infliximab and Vedolizumab for Patients with Ulcerative Colitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Infliximab
    • Vedolizumab
    Finland

  • Study on Newborn Brain Conditions Using Sulfur Hexafluoride Ultrasound for Babies with Hypoxic-Ischemic Injury, Stroke, or Infections

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Sulfur Hexafluoride
    Finland
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!